In this article, you will learn how revenue-based financing works in Spain, what eligibility criteria active providers use, how much it really costs compared to giving up equity, and when it makes sense versus ENISA, ICO, CDTI, or venture debt.
Revenue-based financing is an alternative funding mechanism where a company receives capital in exchange for a percentage of its monthly revenue until a pre-agreed multiple of the principal is repaid, typically between 1.3x and 1.6x. It does not require personal guarantees or equity dilution—in its purest form—but its effective cost can equate to an APR of between 10% and 40%, depending on the provider and the repayment speed. Before signing, a founder needs to understand exactly what gears they are setting in motion.
What is revenue-based financing and how does it work in practice?
The mechanics are simple on paper: the provider advances capital, and you repay a fixed percentage of your monthly revenue—generally between 5% and 20%—until the agreed return factor is reached. If you invoice less one month, you pay less. If you invoice more, you finish sooner. The lever is the cadence of your revenue, not a fixed schedule of installments.
The reality of the term sheets circulating in Spain is much rougher. Many revenue-based financing contracts include warrants, equity kickers, or conditional convertibles that are triggered if the startup fails to meet the estimated repayment schedule, or if the provider negotiates information rights and participation in future rounds. Presenting RBF as "non-dilutive financing" without reading those secondary clauses is like saying a car doesn't use gas because it's going downhill.
Infographics circulate that frame RBF as a clean, nuanced-free category, without figures, cost ranges, or concrete eligibility criteria. A founder who walks into a meeting with a provider armed with that type of content signs at a disadvantage. My job is to ensure you arrive armed differently.
Which startups are eligible for revenue-based financing in Spain?
This is where most articles on RBF fail most spectacularly: they define the target audience with a phrase so broad that it excludes no one. That doesn't help; it hurts. The actual eligibility criteria I use with my clients are as follows:
- Minimum sustained MRR: providers active in the Spanish market require between €30,000 and €100,000 in MRR as an entry threshold.
- Revenue history: a minimum of 6 and usually 12 months of verifiable recurring revenue.
- Controlled churn rate: a monthly churn rate higher than 3-5% begins to strain repayment models.
- Customer concentration: If a single client accounts for more than 30-40% of your ARR, most providers will disqualify you immediately.
- Gross margin: Below 60%, RBF starts to squeeze your operating margin. Below 50%, it’s a trap.
Does your company meet these five filters? Then revenue-based financing deserves serious consideration. If it doesn't? Then what you need isn't RBF, but a different conversation.
What is the real cost of revenue-based financing versus equity?
This is the question no founder asks before signing, and the one every founder should ask first. The cost of giving up equity depends on your company's future valuation. The cost of RBF depends on how long it takes you to pay back the multiple. These two gears turn at different speeds depending on the scenario.
Let's take a concrete example: you receive €200,000 with a 1.4x repayment factor, meaning you pay back €280,000. If you do it in 18 months, your effective APR is around 30%. If your startup is growing at 15% per month and is worth three times as much in 18 months, diluting 8% would have been cheaper. If your growth is steady but not spectacular, RBF wins the comparison.
The rule I apply: if your projected valuation exceeds the implicit cost of the multiple, equity is cheaper. If your growth is predictable but not exponential, RBF preserves value. It’s an arithmetic decision, not an ideological one. And any tool that presents this choice as a simplistic rule—"RBF if you don't want to dilute, equity if you want to grow fast"—is selling you intellectual comfort at the expense of your money.
How does revenue-based financing impact burn rate and runway?
This is the most common misconception I see: founders treat RBF as if it were free money that doesn't affect runway because "it's not traditional debt." That is a category error. Every euro you pay in monthly repayments is a euro that leaves your operating cash flow.
If you have a burn rate of €50,000 per month and you add an RBF repayment of €7,500 per month, your effective burn rate is €57,500. Your runway shortens. That shows up in the due diligence for your next round. A Series A investor who sees that percentage of revenue committed to repayments may interpret it as a sign that your unit economics cannot support debt, or that you weren't able to raise equity on good terms. It may be unfair, but it's real.
The principle I use with my clients: the monthly RBF payment should not increase your burn rate by more than 10%. If you pay €5,000 a month in RBF and your burn was €50,000, you are at the limit. If it goes up to €60,000, you are compromising the metrics that matter for the next round.
What alternatives to revenue-based financing exist in the Spanish ecosystem?
The alternative financing landscape in Spain is richer than most articles on RBF acknowledge. Any article that fails to position RBF within that broader map is doing marketing, not analysis.
These are the levers you should compare before choosing revenue-based financing:
- ENISA participatory loans: non-dilutive, lower cost than RBF, institutional backing. The variable interest is tied to results, but the effective APR is usually below 15%. If you are eligible, ENISA almost always wins the cost comparison.
- ICO credit lines: bank financing with a partial state guarantee. Low cost, but they require collateral and a clean credit history. Not always compatible with an early-stage startup profile.
- CDTI repayable advances: if your startup has a technological or R&D component, CDTI repayable advances are non-dilutive and have reduced interest rates. The process is slow, but the cost is unbeatable.
- Venture debt: for startups that have already raised an equity round and have VC backing, venture debt can be more efficient than RBF in terms of cost and market signaling. We go into the details of the equity kicker and when it makes sense compared to an equity round in Venture Debt: a financial option for growing startups.
Can RBF coexist with public funding? It depends on the specific conditions of each instrument. Some are compatible; others are not. That regulatory due diligence is part of the work that must be done before signing any term sheet.
When does it make sense to use revenue-based financing as a tactical tool?
At Intelectium, we have supported over 50 private investment rounds for seed and Series A/B startups, and the verdict on RBF is consistent: it is a tactical tool, not a strategic one. Useful at a specific moment, but dangerous as a permanent financing philosophy.
It makes sense when:
- You are a SaaS company with over €50,000 in MRR, a gross margin above 70%, and steady, though not hyperbolic, growth.
- You need between €100,000 and €500,000 for marketing or product development without diluting your equity before a Series A round.
- The monthly repayment does not increase your burn rate by more than 10%.
- You have compared the effective cost against ENISA and venture debt, and RBF is the better option in terms of timing or eligibility.
It does not make sense when:
- You are at the pre-seed stage, burning cash to validate PMF.
- Your growth is erratic or dependent on a single major client.
- You plan to raise a Series A in less than 12 months and do not want to compromise your efficiency metrics.
- Your gross margin is below 60%.
Frequently asked questions
Is revenue-based financing always non-dilutive?
Not always. In its standard form, it does not cause dilution, but many contracts in the Spanish market include warrants, equity kickers, or convertible clauses that can dilute the founder if the estimated repayment schedules are not met. Read the secondary clauses carefully before signing.
What does revenue-based financing actually cost?
The typical return factor in Spain ranges from 1.1x to 1.6x the capital advanced, with a flat fee of between 6% and 12% among various active providers in Europe. Depending on the repayment speed, the effective APR can range from 10% to over 35-40% in scenarios involving very fast repayment or stacked instruments. Always compare that cost with public instruments like ENISA or CDTI before committing.
What is the minimum MRR required to access revenue-based financing?
Providers active in Spain generally require between €30,000 and €100,000 in sustained MRR, with a minimum track record of 6 to 12 months. Below that threshold, the risk profile does not fit the variable repayment model.
Does revenue-based financing affect future equity rounds?
Yes. A percentage of revenue committed to repayments appears in the due diligence of any Series A investor and can be interpreted as a negative signal regarding the efficiency of the model or the ability to raise equity. Calculate the impact on your unit economics before committing.
Can revenue-based financing be combined with Spanish public funding?
It depends on the instrument. RBF is compatible with some ENISA and ICO lines, but not necessarily with CDTI repayable advances, which have restrictions on simultaneous financing. Specific conditions must be reviewed on a case-by-case basis.
Revenue-based financing has a specific cost and a concrete range of application. A costly mistake is choosing it because it sounds like "financing without consequences": all capital has a price, and the question is whether that price makes sense for the exact stage your company is in.
